Cargando…
Reprofiling a classical anthelmintic, pyrvinium pamoate, as an anti-cancer drug targeting mitochondrial respiration
Pyrvinium pamoate (PP) is an FDA-approved classical anthelmintic, but is now attracting particular attention as an anti-cancer drug after recent findings of its potent cytotoxicity against various cancer cell lines only during glucose starvation, as well as its anti-tumor activity against hypovascul...
Autores principales: | Ishii, Isao, Harada, Yasuo, Kasahara, Tadashi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Research Foundation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3462317/ https://www.ncbi.nlm.nih.gov/pubmed/23061049 http://dx.doi.org/10.3389/fonc.2012.00137 |
Ejemplares similares
-
Pyrvinium Pamoate: Past, Present, and Future as an Anti-Cancer Drug
por: Schultz, Christopher W., et al.
Publicado: (2022) -
Anthelmintic pyrvinium pamoate blocks Wnt/β-catenin and induces apoptosis in multiple myeloma cells
por: Xu, Fang, et al.
Publicado: (2020) -
The Antihelmintic Drug Pyrvinium Pamoate Targets Aggressive Breast Cancer
por: Xu, Wei, et al.
Publicado: (2013) -
An Anthelmintic Drug, Pyrvinium Pamoate, Thwarts Fibrosis and Ameliorates Myocardial Contractile Dysfunction in a Mouse Model of Myocardial Infarction
por: Murakoshi, Motoaki, et al.
Publicado: (2013) -
Repurposing the FDA-approved anthelmintic pyrvinium pamoate for pancreatic cancer treatment: study protocol for a phase I clinical trial in early-stage pancreatic ductal adenocarcinoma
por: Ponzini, Francesca M, et al.
Publicado: (2023)